Skip header and navigation

Narrow By

   MORE

145 records – page 4 of 8.

Hormone therapy for prostate cancer

https://libcat.nshealth.ca/en/permalink/chpams37500
Nova Scotia Health Authority. GU Cancer Site Team. [Halifax, NS]: Nova Scotia Health Cancer Care Program , 2021.
Pamphlet Number
4010
Available Online
View Pamphlet
The prostate is a gland that makes seminal fluid. Prostate cancer is a disease where cancer cells start to grow in the prostate gland. These cancer cells grow into a tumor and can spread to other parts of the body such as the bones and lymph nodes. This pamphlet explains what causes prostate cancer, what hormones are, what testosterone does, how hormone therapy works for prostate cancer, how long you will be on hormone therapy, and side effects. A list of resources for further information is pr…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. GU Cancer Site Team
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Health Cancer Care Program
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Prostatic Neoplasms
Hormones
Subjects (LCSH)
Prostate--Cancer--Treatment
Specialty
Cancer Care
Urogenital System
Abstract
The prostate is a gland that makes seminal fluid. Prostate cancer is a disease where cancer cells start to grow in the prostate gland. These cancer cells grow into a tumor and can spread to other parts of the body such as the bones and lymph nodes. This pamphlet explains what causes prostate cancer, what hormones are, what testosterone does, how hormone therapy works for prostate cancer, how long you will be on hormone therapy, and side effects. A list of resources for further information is provided.
Responsibility
Prepared by: GU Cancer Site Team; Approved by: Nova Scotia Cancer Patient Education Committee
Pamphlet Number
4010
Less detail

Immune checkpoint inhibitors : a guide for cancer patients

https://libcat.nshealth.ca/en/permalink/chpams38160
Nova Scotia Health. Cancer Care Program. Halifax, NS: Nova Scotia Health Cancer Care Program , 2023.
Pamphlet Number
4040
Available Online
View Pamphlet
Immune checkpoint inhibitors (CPIs) (also called immunotherapy) are an important part of treating some types of cancer. CPIs work by helping your own immune system to work harder or smarter to attack cancer cells. This pamphlet explains what your immune system does and how cancer affects it, what CPIs are and whether they are the same as chemotherapy, and what precautions you have to take. Information about side effects and your orange alert card is included. A list of resources for more inform…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Cancer Care Program
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Immune Checkpoint Inhibitors
Immunotherapy
Neoplasms - drug therapy
Subjects (LCSH)
Cancer--Immunotherapy
Specialty
Cancer Care
Abstract
Immune checkpoint inhibitors (CPIs) (also called immunotherapy) are an important part of treating some types of cancer. CPIs work by helping your own immune system to work harder or smarter to attack cancer cells. This pamphlet explains what your immune system does and how cancer affects it, what CPIs are and whether they are the same as chemotherapy, and what precautions you have to take. Information about side effects and your orange alert card is included. A list of resources for more information is given.
Responsibility
Prepared by: Nova Scotia Health Cancer Care Program; Approved by: Nova Scotia Cancer Education Committee
Pamphlet Number
4040
Less detail

Infliximab therapy for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams34944
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1140
Available Online
View Pamphlet
Your health care provider feels that treatment with infliximab may help you to manage your inflammatory bowel disease (IBD). This pamphlet describes what infliximab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (12 p.) : digital, PDF file
Subjects (MeSH)
Inflammatory Bowel Diseases - drug therapy
Infliximab
Subjects (LCSH)
Inflammatory bowel diseases
Infliximab
Abstract
Your health care provider feels that treatment with infliximab may help you to manage your inflammatory bowel disease (IBD). This pamphlet describes what infliximab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Notes
Previous title: Infliximab (Remicade) therapy
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
1140
Less detail

Information for Female Patients Receiving Radiation Therapy Treatment to the Pelvis

https://libcat.nshealth.ca/en/permalink/chpams37406
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2018.
Pamphlet Number
1337
Available Online
View Pamphlet
This pamphlets provides information for patients receiving radiation therapy to the pelvis. Answers common questions like: what will happen during your treatment, how long are the treatments, and what are the possible side effects of radiation therapy.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Aftercare
Female
Pelvic Neoplasms - radiotherapy
Urogenital Neoplasms - radiotherapy
Subjects (LCSH)
Genitourinary organs--Cancer--Radiotherapy
Pelvis--Cancer--Radiotherapy
Self-care, Health
Specialty
Gynecology
Radiotherapy
Abstract
This pamphlets provides information for patients receiving radiation therapy to the pelvis. Answers common questions like: what will happen during your treatment, how long are the treatments, and what are the possible side effects of radiation therapy.
Notes
Patient & family guide
Responsibility
prepared by Nova Scotia Cancer Care Program
Pamphlet Number
1337
Less detail

Information for Male Patients Receiving Radiation Therapy Treatment to the Pelvis

https://libcat.nshealth.ca/en/permalink/chpams37407
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2018.
Pamphlet Number
1338
Available Online
View Pamphlet
Cancer may be treated with a combination of treatments, radiation therapy is used to shrink cancer and lower the chance of it returning. This pamphlets describes how to prepare for the appointments, what will happen during your treatment, how long the treatments will take, and the possible side effects with coping strategies such as changing eating habits. The pamphlet describes the supports available to you and questions to ask your health care team.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Aftercare
Male
Pelvic Neoplasms - radiotherapy
Urogenital Neoplasms - radiotherapy
Subjects (LCSH)
Pelvis--Cancer--Radiotherapy
Genitourinary organs--Cancer--Radiotherapy
Self-care, Health
Specialty
Men's Health
Radiotherapy
Abstract
Cancer may be treated with a combination of treatments, radiation therapy is used to shrink cancer and lower the chance of it returning. This pamphlets describes how to prepare for the appointments, what will happen during your treatment, how long the treatments will take, and the possible side effects with coping strategies such as changing eating habits. The pamphlet describes the supports available to you and questions to ask your health care team.
Notes
Patient & family guide
Responsibility
prepared by Nova Scotia Cancer Care Program
Pamphlet Number
1338
Less detail

Information for patients receiving radiation therapy : breast cancer or ductal carcinoma in situ (DCIS) of the breast

https://libcat.nshealth.ca/en/permalink/chpams37400
Nova Scotia Health Authority. Cancer Care Program. [Halifax, NS]: Nova Scotia Health Cancer Care Program , 2021.
Pamphlet Number
4008
Available Online
View Pamphlet
This pamphlets answers common questions about receiving radiation therapy for breast cancer or Ductal Carcinoma in Situ (DCIS) of the breast. Topics include why radiation therapy is used to treat breast cancer or DCIS, what will happen when you come for your treatment planning, how long it will be until you start your radiation treatments, and how long your treatments will take. Information about side effects and support is also provided. A list of questions you may want to ask your health care…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Health Cancer Care Program
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Aftercare
Breast Neoplasms - radiotherapy
Self Care
Subjects (LCSH)
Breast--Cancer--Patients--Care
Breast--Cancer--Treatment
Self-care, Health
Specialty
Cancer Care
Abstract
This pamphlets answers common questions about receiving radiation therapy for breast cancer or Ductal Carcinoma in Situ (DCIS) of the breast. Topics include why radiation therapy is used to treat breast cancer or DCIS, what will happen when you come for your treatment planning, how long it will be until you start your radiation treatments, and how long your treatments will take. Information about side effects and support is also provided. A list of questions you may want to ask your health care team is included.
Responsibility
Prepared by: Nova Scotia Health Cancer Care Program; Approved by: Nova Scotia Cancer Patient Education Committee
Pamphlet Number
4008
Less detail

Information for patients receiving radiation therapy : cystitis

https://libcat.nshealth.ca/en/permalink/chpams37405
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Health Cancer Care Program , 2024.
Pamphlet Number
4068
Available Online
View Pamphlet
Cystitis is an irritation and inflammation of the bladder lining. This is a common side effect when radiation treatment is given to the pelvis. This pamphlet describes symptoms of cystitis, when it can happen, and what to do if you think you have it.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Health Cancer Care Program
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Cystitis
Radiotherapy - adverse effects
Subjects (LCSH)
Cystitis
Radiotherapy--Complications
Specialty
Cancer Care
Abstract
Cystitis is an irritation and inflammation of the bladder lining. This is a common side effect when radiation treatment is given to the pelvis. This pamphlet describes symptoms of cystitis, when it can happen, and what to do if you think you have it.
Responsibility
Prepared by: Nova Scotia Health Cancer Care Program
Pamphlet Number
4068
Less detail

Information for patients receiving radiation therapy : diarrhea

https://libcat.nshealth.ca/en/permalink/chpams37392
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2024.
Pamphlet Number
4064
Available Online
View Pamphlet
Diarrhea is a common side effect of radiation treatment to the pelvis. This pamphlet describes why and when someone may have diarrhea and how to treat it. It includes details on diet changes that may helpf.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Diarrhea - prevention & control
Pelvic Neoplasms - complications
Radiotherapy - adverse effects
Subjects (LCSH)
Diarrhea--Treatment
Pelvis--Cancer--Radiotherapy--Complications
Specialty
Cancer Care
Abstract
Diarrhea is a common side effect of radiation treatment to the pelvis. This pamphlet describes why and when someone may have diarrhea and how to treat it. It includes details on diet changes that may helpf.
Responsibility
Prepared by: Nova Scotia Health Cancer Care Program
Pamphlet Number
4064
Less detail

Information for patients receiving radiation therapy : external beam treatment for prostate cancer

https://libcat.nshealth.ca/en/permalink/chpams37395
Nova Scotia Health. Cancer Care Program. Halifax, NS: Nova Scotia Health Cancer Care Program , 2024.
Pamphlet Number
4060
Available Online
View Pamphlet
This pamphlet explains why radiation therapy is used to treat prostate cancer, including how to get ready for your treatments, possible side effects, and questions you may want to ask your health care team.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Cancer Care Program
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Aftercare
Prostatic Neoplasms - radiotherapy
Subjects (LCSH)
Prostate--Cancer--Radiotherapy
Self-care, Health
Specialty
Cancer Care
Abstract
This pamphlet explains why radiation therapy is used to treat prostate cancer, including how to get ready for your treatments, possible side effects, and questions you may want to ask your health care team.
Responsibility
Prepared by: Nova Scotia Health Cancer Care Program
Pamphlet Number
4060
Less detail

Information for Patients Receiving Radiation Therapy : Total Marrow Irradiation (TMI)

https://libcat.nshealth.ca/en/permalink/chpams37416
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2018.
Pamphlet Number
1670
Available Online
View Pamphlet
Certain blood cancers and blood disorders are treated with a stem cell transplant. Total Marrow Irradiation (TMI), like chemotherapy, is given to get your body ready for the stem cells. This pamphlet describes why TMI has been recommended, what will happen during treatment, possible side effects, supports available, and suggested questions to ask your health care team.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Aftercare
Hematologic Diseases - therapy
Hematopoietic Stem Cell Transplantation
Transplantation Conditioning
Subjects (LCSH)
Blood--Diseases--Treatment
Hematopoietic stem cells--Transplantation
Irradiation
Self-care, Health
Specialty
Radiotherapy
Abstract
Certain blood cancers and blood disorders are treated with a stem cell transplant. Total Marrow Irradiation (TMI), like chemotherapy, is given to get your body ready for the stem cells. This pamphlet describes why TMI has been recommended, what will happen during treatment, possible side effects, supports available, and suggested questions to ask your health care team.
Notes
Patient & family guide
Responsibility
prepared by Nova Scotia Cancer Care Program
Pamphlet Number
1670
Less detail

Information for Patients Receiving Radiation Therapy : Treatment to the Abdomen

https://libcat.nshealth.ca/en/permalink/chpams37394
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2018.
Pamphlet Number
1231
Available Online
View Pamphlet
Provides information for patients receiving radiation therapy to the abdomen, including what to expect, how to prepare, side effects, and suggested questions to ask your health care team.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Aftercare
Subjects (LCSH)
Abdomen--Cancer--Radiotherapy
Self-care, Health
Specialty
Radiotherapy
Abstract
Provides information for patients receiving radiation therapy to the abdomen, including what to expect, how to prepare, side effects, and suggested questions to ask your health care team.
Notes
Patient & family guide
Responsibility
prepared by Nova Scotia Cancer Care Program
Pamphlet Number
1231
Less detail

Information for Patients Receiving Radiation Therapy : Treatment to the Chest Area

https://libcat.nshealth.ca/en/permalink/chpams37399
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2018.
Pamphlet Number
1241
Available Online
View Pamphlet
This pamphlets provides information for patients receiving radiation therapy to the chest area. Answers common questions like: what will happen during your treatment, how long are the treatments, and what are the possible side effects of radiation therapy.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Aftercare
Thoracic Neoplasms - radiotherapy
Subjects (LCSH)
Chest--Cancer--Radiotherapy
Self-care, Health
Specialty
Radiotherapy
Abstract
This pamphlets provides information for patients receiving radiation therapy to the chest area. Answers common questions like: what will happen during your treatment, how long are the treatments, and what are the possible side effects of radiation therapy.
Notes
Patient & family guide
Responsibility
prepared by Nova Scotia Cancer Care Program
Pamphlet Number
1241
Less detail

Information on vaginal dilators and lubricants following radiation therapy to the pelvis

https://libcat.nshealth.ca/en/permalink/chpams37454
Nova Scotia Health Authority. Cancer Care Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
4003
Available Online
View Pamphlet
This Nova Scotia resource provides some examples of dilators and lubricants that can be used for vaginal dilation after pelvic radiation. Please refer to the booklet “Use of Vaginal Dilators Following Radiation Therapy to the Pelvis” for more information. Examples of sets of dilators, individual dilators, and vaginal lubricants are given. Contact information for further questions is included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Cancer Care Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Pelvic Neoplasms - radiotherapy
Radiotherapy - adverse effects
Self Care
Vagina
Subjects (LCSH)
Pelvis--Cancer--Radiotherapy--Complications
Self-care, Health
Vagina
Specialty
Cancer Care
Abstract
This Nova Scotia resource provides some examples of dilators and lubricants that can be used for vaginal dilation after pelvic radiation. Please refer to the booklet “Use of Vaginal Dilators Following Radiation Therapy to the Pelvis” for more information. Examples of sets of dilators, individual dilators, and vaginal lubricants are given. Contact information for further questions is included.
Responsibility
Prepared by: Nova Scotia Health Cancer Care Program
Pamphlet Number
4003
Less detail

Injectable iron and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35408
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1495
Available Online
View Pamphlet
Many people with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects. The French version of this pamphlet 2161, "Fer injectable et insuffisance rénale chronique (IRC)," is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Iron - therapeutic use
Kidney Diseases
Anemia, Iron-Deficiency
Subjects (LCSH)
Hemodialysis
Chronic renal failure--Complications
Iron deficiency anemia
Abstract
Many people with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects. The French version of this pamphlet 2161, "Fer injectable et insuffisance rénale chronique (IRC)," is also available.
Notes
Previous title: Injectable iron sucrose and chronic kidney disease
Responsibility
Prepared by: Renal Program
Pamphlet Number
1495
Less detail

Injection de Botox

https://libcat.nshealth.ca/en/permalink/chpams35837
Nova Scotia Health Authority. Eye Care Centre. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1783
Available Online
View Pamphlet
Les injections de Botox peuvent être utilisées pour traiter votre blépharospasme (clignotement rapide des yeux) ou vos spasmes musculaires faciaux. Le Botox arrête les spasmes en bloquant les produits chimiques qui les causent. Le Botox ne guérit pas. Il offre plutôt un soulagement temporaire des symptômes. Le présent dépliant explique comment se préparer aux injections, traitements et effets secondaires. ; This pamphlet is a French translation of "Botox® Injection" pamphlet 0282. Botox injecti…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Eye Care Centre
Alternate Title
Botox injection
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
French
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Blepharospasm - drug therapy
Eye movements
Injections
Subjects (LCSH)
Eyelids--Diseases
Botulinum toxin
Specialty
Ophthalmology
Abstract
Les injections de Botox peuvent être utilisées pour traiter votre blépharospasme (clignotement rapide des yeux) ou vos spasmes musculaires faciaux. Le Botox arrête les spasmes en bloquant les produits chimiques qui les causent. Le Botox ne guérit pas. Il offre plutôt un soulagement temporaire des symptômes. Le présent dépliant explique comment se préparer aux injections, traitements et effets secondaires.
This pamphlet is a French translation of "Botox® Injection" pamphlet 0282. Botox injections may be used to treat blepharospasm (rapid eye blinking) or facial muscle spasms. Botox blocks the chemicals that are causing the spasms and they go away. Botox is not a cure but gives temporary relief from symptoms. This pamphlet describes getting ready for the injection, treatment, and side effects.
Responsibility
Prepared by: Eye Care Centre
Pamphlet Number
1783
Less detail

Injections for chronic pain

https://libcat.nshealth.ca/en/permalink/chpams35004
Nova Scotia Health Authority. QEII. Pain Management Unit. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
0277
Available Online
View Pamphlet
You and your doctor have decided that you need injections to manage your chronic (ongoing) pain. An injection is medication given using a needle. This pamphlet explains how well injections for chronic pain work, if the injections are painful, and common types of injections for chronic pain, including epidural steroids, facet joint injection, sacroiliac (SI joint) injection, and radiofrequency lesioning (RFG). The pamphlet also explains how to get ready for your injections, how an injection for …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Pain Management Unit
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Injections
Pain Management
Subjects (LCSH)
Injections
Pain--Treatment
Specialty
Pain Management
Abstract
You and your doctor have decided that you need injections to manage your chronic (ongoing) pain. An injection is medication given using a needle. This pamphlet explains how well injections for chronic pain work, if the injections are painful, and common types of injections for chronic pain, including epidural steroids, facet joint injection, sacroiliac (SI joint) injection, and radiofrequency lesioning (RFG). The pamphlet also explains how to get ready for your injections, how an injection for chronic pain is done, and the possible side effects and risks.
Notes
Previous title: Nerve block for chronic pain
Previous title: A nerve block for chronic pain
Responsibility
Prepared by: Pain Management Unit
Pamphlet Number
0277
Less detail

Interaction des contraceptifs avec le sugammadex (Bridion™)

https://libcat.nshealth.ca/en/permalink/chpams37519
Nova Scotia Health Authority. QEII. Department of Anesthesia. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
2202
Available Online
View Pamphlet
Pendant votre chirurgie, vous avez reçu un médicament qui diminue l’efficacité de certaines méthodes de contraception hormonale. Le sugammadex (Bridion) a été utilisé pour inverser les effets du relaxant musculaire qu’on vous a administré pendant votre chirurgie. Il peut réduire l’efficacité des contraceptifs hormonaux pendant 7 jours (une semaine). Vous devez donc utiliser une méthode de contraception additionnelle pendant 7 jours après votre chirurgie. ; This pamphlet is a French translation …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Department of Anesthesia
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([1] p.) : digital, PDF file
Subjects (MeSH)
Sugammadex - adverse effects
Hormonal Contraception
Subjects (LCSH)
Sugammadex
Specialty
Gynecology
Abstract
Pendant votre chirurgie, vous avez reçu un médicament qui diminue l’efficacité de certaines méthodes de contraception hormonale. Le sugammadex (Bridion) a été utilisé pour inverser les effets du relaxant musculaire qu’on vous a administré pendant votre chirurgie. Il peut réduire l’efficacité des contraceptifs hormonaux pendant 7 jours (une semaine). Vous devez donc utiliser une méthode de contraception additionnelle pendant 7 jours après votre chirurgie.
This pamphlet is a French translation of "Birth Control medication Interaction with Sugammadex (Bridion™)" pamphlet 2076. During your surgery, you received medication that affects how well birth control medications work. You need to be aware of this if you are on any type of hormonal contraceptive (birth control medication). Sugammadex (Bridion™) is a medication that helps to speed up recovery from the muscle relaxant used during your surgery. Sugammadex may lower how well your hormonal birth control works for up to 7 days (1 week). You must use a back-up birth control method for 7 days after your surgery.
Responsibility
Prepared by: Department of Anesthesia
Pamphlet Number
2202
Less detail

Intravenous Immunoglobulin (IVIG)

https://libcat.nshealth.ca/en/permalink/chpams36584
Nova Scotia Health Authority. QEII. Perioperative Blood Management Service. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1247
Available Online
View Pamphlet
IVIG is a collection of antibodies. Antibodies help your body fight infection. IVIG comes from the plasma (part of the blood) of thousands of different donors. IVIG is available under many brand names (like Gamunex®, IGIVnex®, Gammagard Liquid®, and others). This pamphlet explains how IVIG is given, benefits, and possible side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Perioperative Blood Management Service
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Immunoglobulins, Intravenous
Autoimmune Diseases - drug therapy
Subjects (LCSH)
Immunoglobulins
Autoimmune diseases
Specialty
Hematology
Abstract
IVIG is a collection of antibodies. Antibodies help your body fight infection. IVIG comes from the plasma (part of the blood) of thousands of different donors. IVIG is available under many brand names (like Gamunex®, IGIVnex®, Gammagard Liquid®, and others). This pamphlet explains how IVIG is given, benefits, and possible side effects.
Responsibility
Prepared by: Perioperative Blood Management Service
Pamphlet Number
1247
Less detail

IV (intravenous) iron dextran therapy

https://libcat.nshealth.ca/en/permalink/chpams35379
Nova Scotia Health Authority. QEII. Perioperative Blood Management Service. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1443
Available Online
View Pamphlet
Iron is a mineral that the body needs to make hemoglobin in red blood cells. Sometimes iron must be given by IV before or after surgery. This pamphlet reviews how iron is given, a list of iron-rich foods, possible side effects, what to do after receiving iron therapy, and who to call should you have any problems.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Perioperative Blood Management Service
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Iron
Iron-Dextran Complex
Subjects (LCSH)
Iron in the body
High-iron diet
Abstract
Iron is a mineral that the body needs to make hemoglobin in red blood cells. Sometimes iron must be given by IV before or after surgery. This pamphlet reviews how iron is given, a list of iron-rich foods, possible side effects, what to do after receiving iron therapy, and who to call should you have any problems.
Responsibility
Prepared by: Perioperative Blood Management Service, QEII
Pamphlet Number
1443
Less detail

IV (intravenous) iron therapy

https://libcat.nshealth.ca/en/permalink/chpams36485
Nova Scotia Health Authority. Perioperative Blood Management Service. Halifax, NS: Nova Scotia Health Authority , 2018.
Pamphlet Number
1332
Available Online
View Pamphlet
Iron is a mineral that the body needs to make red blood cells. When the body does not get enough iron, it can't make enough red blood cells to keep you healthy. This is called iron deficiency or iron deficiency anemia. This pamphlet outlines the symptoms, treatment, when this specific method is used, how therapy is given, and possible side effects. A list of health problems in which iron cannot be used as therapy is provided. Followup instructions and contact information is also given.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Perioperative Blood Management Service
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Anemia, Iron-Deficiency - therapy
Subjects (LCSH)
Anemia
Abstract
Iron is a mineral that the body needs to make red blood cells. When the body does not get enough iron, it can't make enough red blood cells to keep you healthy. This is called iron deficiency or iron deficiency anemia. This pamphlet outlines the symptoms, treatment, when this specific method is used, how therapy is given, and possible side effects. A list of health problems in which iron cannot be used as therapy is provided. Followup instructions and contact information is also given.
Responsibility
Prepared by: Perioperative Blood Management Service; Department of Anesthesia, HI
Pamphlet Number
1332
Less detail

145 records – page 4 of 8.